Medindia

X

New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan

Monday, June 21, 2010 Drug News J E 4
Advertisement
Data from comparator trial presented at the European Society of Hypertension (ESH) Annual Scientific Meeting

Contacts:

Jaimee Lumm

Elissa J. Johnsen

GolinHarris

Takeda Pharmaceuticals North America

312-729-4276

224-554-3185

jlumm@golinharris.com

ejohnsen@tpna.com

Josephine Zammuto

Takeda Global Research & Development

847-582-5971

josephine.zammuto@tpna.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NIH and Wellcome Trust Announce Partnership With A...
S
World Diet Food and Confectionery Market (2010 -20...